% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://docs.db.ripe.net/terms-conditions.html

% Note: this output has been filtered.
%       To receive output for a database update, use the "-B" flag.

% Information related to '145.240.0.0 - 145.240.255.255'

% Abuse contact for '145.240.0.0 - 145.240.255.255' is 'cstd@gsk.com'

inetnum:        145.240.0.0 - 145.240.255.255
netname:        GLAXOSMITHKLINE
org:            ORG-GPU2-RIPE
country:        FR
admin-c:        Ga4002-RIPE
tech-c:         Ga4002-RIPE
status:         ASSIGNED PI
mnt-by:         RIPE-NCC-END-MNT
mnt-by:         GSK-MNT
created:        1970-01-01T00:00:00Z
last-modified:  2026-08-12T07:50:28Z
source:         RIPE # Filtered

organisation:   ORG-GPU2-RIPE
org-name:       Glaxo Wellcome UK Limited
org-type:       OTHER
address:        Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, United Kingdom, SG1 2NY
country:        GB
reg-nr:         00480080
abuse-c:        Ga4002-RIPE
mnt-ref:        GSK-mnt
mnt-by:         GSK-mnt
created:        2026-08-10T13:32:38Z
last-modified:  2026-08-11T08:55:02Z
source:         RIPE # Filtered

role:           GSK admin
address:        1250 South Collegeville Road, Collegeville PA 19426 USA
mnt-by:         gsk-mnt
abuse-mailbox:  cstd@gsk.com
nic-hdl:        Ga4002-RIPE
created:        2007-06-07T15:29:08Z
last-modified:  2025-08-18T15:56:11Z
source:         RIPE # Filtered

% This query was served by the RIPE Database Query Service version 1.124.1 (SHETLAND)